2C-B is a synthetic phenethylamine psychedelic with both hallucinogenic and empathogenic properties. Known for visual intensity and euphoria with a clear headspace. Dose-sensitive: small variations dramatically alter the experience. Unpredictable potency and frequent adulteration make it high-risk. Increasingly prevalent in club and chemsex scenes.
How It Works
Partial agonist at serotonin 5-HT2A and 5-HT2C receptors, mediating psychedelic and hallucinogenic effects. May also interact with dopamine receptors (D2, D3) contributing to empathogenic properties. Acts as a releasing agent for serotonin and dopamine.
Legal Status
Controlled in most countries. Classified as a Schedule I substance in the US and similarly restricted internationally. Illegal for all non-research purposes.
Dosage Guide (Oral)
| Level | Amount (milligrams (mg)) |
|---|---|
| Threshold | 5-10 mg |
| Light | 10-15 mg |
| Common | 15-25 mg |
| Strong | 25-35 mg |
| Heavy | 35+ mg |
Note: Dose-sensitive: 5mg difference between light and intense experiences. Poorly dosed or adulterated substances are extremely common. No reliable street doses exist. Insufflation typically requires 30-50% less material but causes severe nasal irritation. Purity and potency vary dramatically between batches.
Organ System Impacts
- cardiovascular — Moderate
- Increases heart rate, blood pressure, and cardiac workload. Risk of arrhythmias, palpitations, and in rare cases myocardial infarction, especially in susceptible individuals or at high doses.
- neurological — Moderate
- Potent serotonergic activity produces hallucinations, dissociation, and altered cognition. Hallucinogenic effects can trigger latent psychotic disorders. Seizure risk in susceptible individuals at high doses.
- ocular — Low
- Pupil dilation (mydriasis), visual distortions, and enhanced color perception. Possible photophobia. No permanent ocular damage reported, but impaired vision during acute effects.
- dermatological — Low
- Profuse sweating common, especially in club/dance settings. Hyperthermia risk in hot environments. Possible rash from adulterated substances.
- respiratory — Low
- No direct respiratory toxicity. Mild tachypnea possible from sympathomimetic effects. Hyperthermia may increase respiratory rate.
- hepatic — Low
- Minimal hepatic toxicity reported. Metabolism primarily via monoamine oxidase and other liver enzymes. No significant liver damage in acute or chronic use documented.
- hematological — Low
- No direct hematological effects. Possible dehydration in prolonged use in hot environments affecting blood volume and viscosity.
- renal — Low
- Sympathomimetic effects may cause hypertension affecting renal perfusion. Dehydration and SIADH-like effects possible. Risk of rhabdomyolysis and acute kidney injury if hyperthermia occurs.
- gastrointestinal — Low
- Nausea and vomiting common, particularly with oral route and higher doses. Possible stomach cramping and diarrhea. Appetite suppression during acute effects.
- musculoskeletal — Low
- Jaw clenching and teeth grinding (bruxism) common. Muscle tension and rigidity possible at higher doses. Risk of rhabdomyolysis with hyperthermia in dance/exertion settings.
Effects
Desired Effects
- Euphoria
- Intense visuals
- Emotional openness
- Sensory enhancement
- Increased empathy
- Laughter
- Music enhancement
- Connection with others
Negative Effects
- Anxiety
- Paranoia
- Nausea and vomiting
- Jaw clenching/tension
- Muscle tension
- Rapid heartbeat
- Restlessness
- Difficulty sleeping
Rare but Serious
- Severe anxiety or panic attack
- Serotonin syndrome
- Seizures
- Acute psychosis
- Cardiac arrhythmias
- Hypertensive crisis
Drug Interactions
MAOI antidepressants (phenelzine, tranylcypromine) and certain antidepressants — dangerous
Severe serotonin syndrome risk. Combined serotonergic activity may cause fatal hypertensive crisis, hyperthermia, seizures, and cardiovascular collapse.
Stimulants (cocaine, amphetamines, methamphetamine, MDMA) — dangerous
Compounded sympathomimetic effects causing severe tachycardia, hypertension, arrhythmias, and hyperthermia. High overdose and sudden cardiac death risk, especially in exertion/club settings.
SSRI antidepressants (sertraline, fluoxetine, paroxetine) — moderate
Increased serotonin syndrome risk, though less severe than with MAOIs. Symptoms include agitation, confusion, rapid heart rate, and hyperthermia. Risk increases with higher 2C-B doses.
Other serotonergic drugs (tramadol, certain opioids, dextromethorphan) — moderate
Additive serotonergic effects increasing serotonin syndrome risk. Tramadol is particularly dangerous. Symptoms include agitation, confusion, muscle rigidity, and hyperthermia.
Cannabis — moderate
Potentiation of psychedelic effects and dissociation. Increased anxiety and paranoia risk. Cannabis may increase tachycardia and cardiovascular stress.
Alcohol — moderate
Impairs judgment and increases risky behavior. Alcohol dehydrates, increasing hyperthermia risk in dance settings. May worsen nausea and increase cardiovascular stress.
Benzodiazepines — low
May reduce anxiety during peak. However, combination may impair judgment and coordination. Benzodiazepines can blunt psychedelic effects if high dose of benzo is used.
Detection Times
2C-B is not detected on standard drug panels. Specialized mass spectrometry testing is required.
Urine
Requires GC-MS or LC-MS/MS. May cross-react on amphetamine assays. Detection window: up to 3 days.
Blood
Short blood detection window. Detection window: up to 1 days.
Hair
Hair testing is theoretically possible but rarely done. Detection window: up to 90 days.
Harm Reduction Tips
- Never use with MAOI antidepressants or certain other antidepressants (SSRIs, tramadol) due to severe serotonin syndrome risk.
- Never combine with stimulants (cocaine, amphetamines, MDMA) due to life-threatening cardiovascular effects.
- Test substance with reagent kits (Marquis, Mecke, Mandelin, Froehde) before consumption. Be aware that 2C-B is frequently mislabeled or adulterated with PMA, NBOMe compounds, or other dangerous substances.
- Start with low doses (10-15 mg oral) to assess individual sensitivity and substance purity. Small dose variations produce dramatically different intensities.
- Stay hydrated and maintain adequate electrolyte balance, especially in hot/dance environments. Drink 250-500mL water per hour in exertion settings, but avoid excessive water intake.
- Monitor body temperature and take breaks from dancing/exertion. Use cool compresses if overheating occurs. Hyperthermia is the primary medical emergency.
- Avoid insufflation whenever possible due to nasal damage risk and unpredictable potency. If snorting, use saline nasal drops pre/post and inspect nasal passages weekly for damage.
- Use in safe, controlled environments with trusted people. Avoid driving or operating machinery. Have a sober trip sitter if possible, especially on higher doses.
- If experiencing severe chest pain, shortness of breath, or uncontrolled rapid heartbeat, seek immediate medical attention.
- Avoid use if you have personal or family history of psychosis, heart disease, or uncontrolled hypertension.
- Practice responsible sexual behavior if using in chemsex contexts. Consent impairment is possible at higher doses.
Withdrawal Symptoms
Severity: Low
Not applicable — 2C-B does not produce dependence.
Psychological
- No significant withdrawal syndrome
Emergency Information
Call 911 If:
- Chest pain or cardiac symptoms
- Severe uncontrolled hypertension
- Hyperthermia above 39°C (102°F)
- Severe confusion or uncontrollable behavior
- Muscle rigidity or severe muscle contractions
- Loss of consciousness or seizures
- Severe respiratory distress
- Any signs of serotonin syndrome
Warning Signs
- Severe chest pain or pressure
- Uncontrollable rapid or irregular heartbeat
- Severe hypertension (headache, dizziness, nosebleeds)
- Uncontrollable high fever (>39°C/102°F)
- Severe agitation, confusion, or hallucinations
- Rigid muscles or uncontrollable muscle contractions
- Loss of consciousness
- Seizures
- Severe breathing difficulty
What To Do
- Immediately move to a cool, well-ventilated area and lie down with feet elevated.
- Cool the body with cold compresses, ice packs, or immersion in cool (not ice) water if hyperthermia.
- Monitor vital signs and consciousness level.
- Sip water slowly if conscious and no vomiting.
- If seizure occurs, protect from injury and position on side.
- Keep person calm and reassured; provide supportive care.
- If symptoms persist or worsen, contact emergency services.